FENNEC PHARMACEUTICALS INC. Operating Lease, Liability, Current
FENNEC PHARMACEUTICALS INC. (FENC) had Operating Lease, Liability, Current of $2.00 thousand as of 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-03-27
- 2024-12-31: Operating Lease, Liability, Current $2.00K.
- 2024-09-30: Operating Lease, Liability, Current $7.00K.
- 2024-06-30: Operating Lease, Liability, Current $12.00K.
- 2024-03-31: Operating Lease, Liability, Current $17.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-12-31 | $2.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $7.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $12.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $17.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $21.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $21.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |